How NGS and PCR Are Advancing Companion Diagnostics for Targeted Therapies
The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek